Pharma major Dr Reddy’s Laboratories Ltd has launched Clofarabine injection, a therapeutic and generic equivalent of Clolar injection of Genzyme Corporation, in the US market.
The Clolar brand and generic had the US sales of approximately $53 million for the most recent 12 months ended September 2017 as per IMS Health, the Hyderabad-based company said in a release issued here on Tuesday. The drug is used in treating a particular type of cancer, among other prescribed use.